Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO —The subcutaneous implantable cardioverter defibrillator successfully treats ventricular ...

Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

Years ago, during training, I remember a colleague dissing an early model of an implantable cardioverter-defibrillator (ICD) because it was primitive. All it did was shock ventricular tachycardia (VT) ...

Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...

Though the PRAETORIAN group was technically unable to prove that 8 years was enough to give a subcutaneous implantable cardioverter-defibrillator (ICD) an edge in safety, complication rates helped ...

Stockholm, Sweden - Early testing of an implantable cardioverter-defibrillator (ICD) featuring a totally subcutaneous lead system suggests the device can terminate ventricular tachyarrhythmias using ...

For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...

Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

Electric shocks delivered by subcutaneous defibrillators are equally effective compared to shocks delivered by conventional transvenous defibrillators, according to a study published in the journal ...